How to Develop an Interface Gap Analysis Document
May 15, 2014
Tip 10 in the Interoperability Tip Series In the previous tip, we covered specifications. Another key requirements or scoping document you’ll need is a gap
Tip 10 in the Interoperability Tip Series In the previous tip, we covered specifications. Another key requirements or scoping document you’ll need is a gap
Tip 9 in the Interoperability Tip Series In Tip 8, we explained what an HL7 interface specification should include. In this tip, learn how to
In our discussions with vendors and providers on these new standards, we’ve seen a wide range of learning curves. Some people are just getting started,
Tip 8 in the Interoperability Tip Series Critical Elements in an HL7 Interface Specification These are critical elements a developer needs to create a interface
Bridging the Gaps In a previous post on CCD, C-CDA, and CDA, we compared HL7 v2 messaging to CCD development. This week’s article is about
Tip 7 in the Interoperability Tip Series Communicating These Needs to Leadership These are the most important assets you’ll need when you’re working on creating
Confused? Start with What You Know Over the past few months, we’ve heard a lot from our hospital-based customers about CCD and C-CDA readiness. There’s
Tip 6 in the Interoperability Tip Series This tip is for hospital or provider analysts and team leads. You’ve got a firm grasp of the
The Status Quo This is the world interface analysts, developers, and quality testers work in: 2 weeks to get a list of code values for
Tip 5 in the Interoperability Tip Series 9 Critical Questions You Need to Ask Your Clinical System and Interface Vendors Like our last two tips,
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.